Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by John Ioannidis and Lars Hemkens.
John Ioannidis
Connection Strength
1.402
Lars Hemkens
  1. Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently? Can J Cardiol. 2021 09; 37(9):1353-1364.
    View in: PubMed
    Score: 0.237
  2. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 May 14; 12(1):3001.
    View in: PubMed
    Score: 0.236
  3. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 04 15; 12(1):2349.
    View in: PubMed
    Score: 0.235
  4. Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. JAMA. 2021 03 23; 325(12):1185-1195.
    View in: PubMed
    Score: 0.234
  5. Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic. JAMA Netw Open. 2021 03 01; 4(3):e210330.
    View in: PubMed
    Score: 0.233
  6. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Res. 2020; 9:1193.
    View in: PubMed
    Score: 0.226
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.